双响应的超分子聚合物纳米药物用于自我级联放大癌症免疫疗法
Wenting Hu1,2,3, Binglin Ye1,2,3,4,5,6, Guocan Yu7
1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 17, 2024
概括
这项研究引入了新型纳米颗粒,这些纳米颗粒可触发热 (一种细胞死亡形式) 并抑制免疫抑制,增强癌症免疫疗法的有效性并促进瘤减少.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 瘤免疫性和免疫逃生限制癌症免疫疗法的有效性.
- 热,一种被编程的细胞死亡,可以诱导免疫细胞死亡和长期免疫激活.
- 逆转免疫抑制瘤微环境对于有效的癌症免疫疗法至关重要.
研究的目的:
- 为扩大癌症免疫疗法设计一种双响应的超分子聚合物纳米药物 (NCSNPs).
- 为了研究火灭菌诱导和免疫检查点抑制的联合治疗效果.
- 开发一种新的策略,以克服癌症免疫治疗中常见的挑战.
主要方法:
- 使用β-cyclodextrin,一氧化 (NO) 捐赠剂 (火灭菌激活剂) 和NLG919 (一种氨酸2,3-二氧化酶 (IDO) 抑制剂) 的NCSNP的配方.
- 纳米粒子通过宿主-客分子识别和疏水相互作用进行自我组装.
- 评估瘤积累,生物可用性,热致死诱导,免疫微环境调节和瘤增殖抑制.
主要成果:
- NCSNPs表现出优异的瘤积累和生物可用性.
- 该研究证实了瘤中氧化 (NO) 触发的热亡.
- 通过增强细胞毒性T淋巴细胞透,NCSNPs逆转了免疫抑制性瘤微环境,导致显著的瘤增殖抑制.
结论:
- NCSNP代表了癌症免疫治疗的新型纳米药物策略.
- 诱导热和抑制IDO的双重方法显示出显著的治疗潜力.
- 这项研究为克服瘤免疫逃避和提高治疗结果提供了一个有希望的新途径.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


